Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF homocysteine is not elevated in schizophrenia.

J Levine1, G Agam, B A Sela

  • 1Stanley Research Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel.

Journal of Neural Transmission (Vienna, Austria : 1996)
|January 20, 2005
PubMed
Summary

High homocysteine levels, a risk factor for vascular and Alzheimer's diseases, were investigated in schizophrenia patients. Cerebrospinal fluid homocysteine levels did not differ between schizophrenia patients and healthy controls in this study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does treatment with autophagy-enhancers and/or ROS-scavengers alleviate behavioral and neurochemical consequences of low-dose rotenone-induced mild mitochondrial dysfunction in mice?

Molecular psychiatry·2023
Same author

Using mitochondrial respiration inhibitors to design a novel model of bipolar disorder-like phenotype with construct, face and predictive validity.

Translational psychiatry·2021
Same author

To the editor: how statistics killed the cat: conclusion.

Psychological medicine·2017
Same author

To the Editor: How statistics killed the cat.

Psychological medicine·2017
Same author

IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.

Translational psychiatry·2016
Same author

Lack of effect of chronic ketamine administration on depression-like behavior and frontal cortex autophagy in female and male ICR mice.

Behavioural brain research·2016

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Homocysteine is a neurotoxic amino acid linked to cardiovascular, cerebrovascular, and Alzheimer's diseases.
  • Elevated plasma homocysteine levels have been observed in schizophrenia patients, particularly young males.
  • Previous research suggests a potential role for homocysteine in schizophrenia pathophysiology.

Purpose of the Study:

  • To investigate cerebrospinal fluid (CSF) homocysteine levels in schizophrenia patients.
  • To determine if CSF homocysteine levels differ between schizophrenia patients and healthy controls.

Main Methods:

  • CSF samples were collected from two groups: schizophrenia patients (N=41) and controls (N=29).
  • Homocysteine levels in CSF were measured using [specific assay not mentioned in abstract].

Related Experiment Videos

Main Results:

  • No statistically significant difference in CSF homocysteine levels was found between schizophrenia patients and control groups (p=.041 for Study A, p=.52 for Study B).
  • This finding contrasts with some previous studies reporting elevated plasma homocysteine in schizophrenia.

Conclusions:

  • CSF homocysteine levels do not appear to be a distinguishing biomarker for schizophrenia in the studied populations.
  • Further research may be needed to clarify the role of homocysteine in schizophrenia, potentially exploring different patient subgroups or disease stages.